SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-154958
Filing Date
2021-05-07
Accepted
2021-05-07 16:17:34
Documents
6
Period of Report
2021-05-07

Document Format Files

Seq Description Document Type Size
1 6-K d409224d6k.htm 6-K 12603
2 EX-99.1 d409224dex991.htm EX-99.1 27698
3 EX-99.2 d409224dex992.htm EX-99.2 31034
4 GRAPHIC g409224g03p11.jpg GRAPHIC 3563
5 GRAPHIC g409224g19b84.jpg GRAPHIC 9172
6 GRAPHIC g409224g31o38.jpg GRAPHIC 4985
  Complete submission text file 0001193125-21-154958.txt   97352
Mailing Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435
Business Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435 32 10 394 100
Celyad Oncology SA (Filer) CIK: 0001637890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37452 | Film No.: 21902927
SIC: 2834 Pharmaceutical Preparations